MoonLake Immunotherapeutics
MLTX | NASDAQ
$12.55
+$0.16 (+1.29%)
At close: Sep 21, 2026, 4:00 PM ET
$12.60
+$0.05 (+0.40%)
Pre-market:
Sep 22, 2026, 8:21 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 845K | 751K | n/a | 742K | n/a | n/a | 32.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.49K | n/a | n/a | n/a |
Gross Profit | n/a | -845K | -751K | n/a | -742K | n/a | n/a | -32.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.49K | n/a | n/a | n/a |
Operating Income | -61.66M | -70.02M | -65.22M | -71.43M | -60.7M | -47.49M | -49.58M | -43.11M | -30.58M | -19.82M | -15.03M | -12.98M | -13.19M | -12.93M | -16.7M | -14.77M | -17.65M | -15.94M | -14.28M | -6.27M | -32.68M | -94.11K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.82K |
Pretax Income | -61.72M | -69.09M | -62.77M | -70.58M | -55.96M | -40.41M | -46.35M | -36.02M | -24.68M | -13.91M | -7.84M | -11.59M | -12.34M | -12.21M | -16.46M | -14.73M | -17.41M | -15.87M | -14.31M | -6.29M | -32.69M | -76.29K |
Net Income | -61.81M | -69.71M | -62.43M | -69.73M | -55.22M | -39.94M | -45.6M | -35.39M | -24.27M | -13.67M | -7.44M | -9.43M | -10.14M | -9M | -1.94M | -10.11M | -12.12M | -15.88M | -14.32M | -6.29M | -32.69M | -76.29K |
Selling & General & Admin | 11.44M | 15.51M | 9.21M | 10.8M | 10.94M | 11.03M | 9.22M | 7.38M | 6.92M | 6.81M | 6.93M | 5.39M | 4.48M | 5.52M | 5.33M | 5.75M | 6.25M | 5.49M | 9.28M | 5.6M | 2.81M | 94.11K |
Research & Development | 50.22M | 53.67M | 57.49M | 60.64M | 49.02M | 36.46M | 40.36M | 35.7M | 23.66M | 13.01M | 8.1M | 7.59M | 8.7M | 7.42M | 11.37M | 9.02M | 11.4M | 10.45M | 4.99M | 669.53K | 29.87M | n/a |
Other Expenses | n/a | n/a | -2.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 61.66M | 69.18M | 64.47M | 71.43M | 59.96M | 47.49M | 49.58M | 43.08M | 30.58M | 19.82M | 15.03M | 12.98M | 13.19M | 12.93M | 16.7M | 14.77M | 17.65M | 15.94M | 14.27M | 6.27M | 32.68M | 94.11K |
Interest Expense | 2.63M | 2.27M | 2M | 3.2M | 2.04M | 18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 61.66M | 70.02M | 65.22M | 71.43M | 60.7M | 47.49M | 49.58M | 43.11M | 30.58M | 19.82M | 15.03M | 12.98M | 13.19M | 12.93M | 16.7M | 14.77M | 17.65M | 15.94M | 14.28M | 6.27M | 32.68M | 94.11K |
Income Tax Expense | 90K | 622K | 248K | 115K | 95K | 153K | 41.14K | 92.11K | 79K | 70K | 44.31K | 28.92K | 10.15K | 11.01K | 11.01K | 8.74K | 9.28K | 7.33K | 4.76K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.92M | 71.27M | 64.46M | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M | 36.93M | 14.81M |
Shares Outstanding (Diluted) | 73.92M | 71.27M | 64.46M | 63.37M | 63.28M | 63.23M | 63.07M | 62.9M | 62.87M | 62.64M | 59.91M | 53.52M | 43.72M | 39.06M | 38.84M | 36.93M | 35.2M | 36.93M | 36.93M | 36.93M | 36.93M | 14.81M |
EPS (Basic) | -0.84 | -0.98 | -0.93 | -1.10 | -0.87 | -0.63 | -0.72 | -0.56 | -0.39 | -0.22 | -0.12 | -0.18 | -0.23 | -0.31 | -0.05 | -0.40 | -0.49 | -0.43 | -0.06 | -0.17 | -0.89 | -0.01 |
EPS (Diluted) | -0.84 | -0.98 | -0.93 | -1.10 | -0.87 | -0.63 | -0.72 | -0.56 | -0.39 | -0.22 | -0.12 | -0.18 | -0.23 | -0.31 | -0.05 | -0.40 | -0.49 | -0.43 | -0.06 | -0.17 | -0.89 | -0.01 |
EBITDA | -58.19M | -65.97M | -60.02M | -66.64M | -53.18M | -40.01M | -45.05M | -35.99M | -24.34M | -13.58M | -7.84M | -11.59M | -12.34M | -12.2M | -16.45M | -14.73M | -17.4M | -15.87M | -14.31M | -6.29M | -32.69M | -76.29K |
EBIT | -59.08M | -66.82M | -60.77M | -67.38M | -53.92M | -40.39M | -46.35M | -36.02M | -24.68M | -13.91M | -7.84M | -11.59M | -12.34M | -12.21M | -16.46M | -14.73M | -17.41M | -15.87M | -14.31M | -6.29M | -32.69M | -76.29K |
Depreciation & Amortization | 896K | 845K | 751K | 745K | 742K | 378K | 1.3M | 32.52K | 342K | 328K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 2.49K | 2.49K | 2.27K | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MLTX